McGill University at ESGCT 2026

Oct 27–30, 2026 Hamburg, Germany ~2.5k attendees Website

McGill University brings 2 presentations to ESGCT 2026 in Hamburg. Its work centres on delivering gene therapy safely in a clinical research setting. It covers a platform for advanced therapies in neurological disorders and how risk is reduced through monitoring and coordination across specialties.

OrganizationESGCT 2026 Attendance
McGill University
Montreal, Canada
Poster
Wed Oct 28
1:30pm–3:30pm
A Platform for Advanced Clinical Therapies (PACT) for neurological disorders
Other
Clinical trials and translation
Poster
Wed Oct 28
1:30pm–3:30pm
Delivering Gene Therapy Safely in the Clinical Research Setting: A Review of Risk Mitigation, Monitoring and Multidisciplinary Coordination
Other
Clinical trials and translation

Explore the full ESGCT 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Hamburg. Leave your work email and we’ll be in touch.

Privacy

Download the full ESGCT 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from McGill University

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the European Society of Gene & Cell Therapy. Submit a correction